-
AstraZeneca’s Three-in-One COPD Inhaler Succeeds in Phase III Trial
- Source: Biospace
- 585
- January 29, 2018
-
FDA approves Adherium’s new inhaler monitoring device
- Source: medicaldevices-business-review
- 576
- September 5, 2017
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
